Literature DB >> 21719641

Altered telomeres in tumors with ATRX and DAXX mutations.

Christopher M Heaphy1, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar, G Johan Offerhaus, Roger McLendon, B Ahmed Rasheed, Yiping He, Hai Yan, Darell D Bigner, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Gregory J Riggins, Kenneth W Kinzler, Bert Vogelstein, Ralph H Hruban, Anirban Maitra, Nickolas Papadopoulos, Alan K Meeker.   

Abstract

The proteins encoded by ATRX and DAXX participate in chromatin remodeling at telomeres and other genomic sites. Because inactivating mutations of these genes are common in human pancreatic neuroendocrine tumors (PanNETs), we examined the telomere status of these tumors. We found that 61% of PanNETs displayed abnormal telomeres that are characteristic of a telomerase-independent telomere maintenance mechanism termed ALT (alternative lengthening of telomeres). All of the PanNETs exhibiting these abnormal telomeres had ATRX or DAXX mutations or loss of nuclear ATRX or DAXX protein. ATRX mutations also correlate with abnormal telomeres in tumors of the central nervous system. These data suggest that an alternative telomere maintenance function may operate in human tumors with alterations in the ATRX or DAXX genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719641      PMCID: PMC3174141          DOI: 10.1126/science.1207313

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.

Authors:  Yutong Xue; Richard Gibbons; Zhijiang Yan; Dafeng Yang; Tarra L McDowell; Salvatore Sechi; Jun Qin; Sharleen Zhou; Doug Higgs; Weidong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

2.  Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.

Authors:  Peter W Lewis; Simon J Elsaesser; Kyung-Min Noh; Sonja C Stadler; C David Allis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-22       Impact factor: 11.205

3.  Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends.

Authors:  Claus M Azzalin; Patrick Reichenbach; Lela Khoriauli; Elena Giulotto; Joachim Lingner
Journal:  Science       Date:  2007-10-04       Impact factor: 47.728

4.  HIRA and Daxx constitute two independent histone H3.3-containing predeposition complexes.

Authors:  S J Elsaesser; C D Allis
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2010-11-03

5.  ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells.

Authors:  Lee H Wong; James D McGhie; Marcus Sim; Melissa A Anderson; Soyeon Ahn; Ross D Hannan; Amee J George; Kylie A Morgan; Jeffrey R Mann; K H Andy Choo
Journal:  Genome Res       Date:  2010-01-28       Impact factor: 9.043

6.  DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.

Authors:  Yuchen Jiao; Chanjuan Shi; Barish H Edil; Roeland F de Wilde; David S Klimstra; Anirban Maitra; Richard D Schulick; Laura H Tang; Christopher L Wolfgang; Michael A Choti; Victor E Velculescu; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Nickolas Papadopoulos
Journal:  Science       Date:  2011-01-20       Impact factor: 47.728

7.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.

Authors:  T R Yeager; A A Neumann; A Englezou; L I Huschtscha; J R Noble; R R Reddel
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

8.  Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells.

Authors:  Lee H Wong; Hua Ren; Evan Williams; James McGhie; Soyeon Ahn; Marcus Sim; Angela Tam; Elizabeth Earle; Melissa A Anderson; Jeffrey Mann; K H Andy Choo
Journal:  Genome Res       Date:  2009-02-05       Impact factor: 9.043

9.  ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.

Authors:  Martin J Law; Karen M Lower; Hsiao P J Voon; Jim R Hughes; David Garrick; Vip Viprakasit; Matthew Mitson; Marco De Gobbi; Marco Marra; Andrew Morris; Aaron Abbott; Steven P Wilder; Stephen Taylor; Guilherme M Santos; Joe Cross; Helena Ayyub; Steven Jones; Jiannis Ragoussis; Daniela Rhodes; Ian Dunham; Douglas R Higgs; Richard J Gibbons
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

10.  Distinct factors control histone variant H3.3 localization at specific genomic regions.

Authors:  Aaron D Goldberg; Laura A Banaszynski; Kyung-Min Noh; Peter W Lewis; Simon J Elsaesser; Sonja Stadler; Scott Dewell; Martin Law; Xingyi Guo; Xuan Li; Duancheng Wen; Ariane Chapgier; Russell C DeKelver; Jeffrey C Miller; Ya-Li Lee; Elizabeth A Boydston; Michael C Holmes; Philip D Gregory; John M Greally; Shahin Rafii; Chingwen Yang; Peter J Scambler; David Garrick; Richard J Gibbons; Douglas R Higgs; Ileana M Cristea; Fyodor D Urnov; Deyou Zheng; C David Allis
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

View more
  439 in total

1.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.

Authors:  Yasushi Totoki; Kenji Tatsuno; Kyle R Covington; Hiroki Ueda; Chad J Creighton; Mamoru Kato; Shingo Tsuji; Lawrence A Donehower; Betty L Slagle; Hiromi Nakamura; Shogo Yamamoto; Eve Shinbrot; Natsuko Hama; Megan Lehmkuhl; Fumie Hosoda; Yasuhito Arai; Kim Walker; Mahmoud Dahdouli; Kengo Gotoh; Genta Nagae; Marie-Claude Gingras; Donna M Muzny; Hidenori Ojima; Kazuaki Shimada; Yutaka Midorikawa; John A Goss; Ronald Cotton; Akimasa Hayashi; Junji Shibahara; Shumpei Ishikawa; Jacfranz Guiteau; Mariko Tanaka; Tomoko Urushidate; Shoko Ohashi; Naoko Okada; Harsha Doddapaneni; Min Wang; Yiming Zhu; Huyen Dinh; Takuji Okusaka; Norihiro Kokudo; Tomoo Kosuge; Tadatoshi Takayama; Masashi Fukayama; Richard A Gibbs; David A Wheeler; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

Review 2.  Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.

Authors:  Roeland F de Wilde; Barish H Edil; Ralph H Hruban; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

3.  ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression.

Authors:  Kajan Ratnakumar; Luis F Duarte; Gary LeRoy; Dan Hasson; Daniel Smeets; Chiara Vardabasso; Clemens Bönisch; Tianying Zeng; Bin Xiang; David Y Zhang; Haitao Li; Xiaowo Wang; Sandra B Hake; Lothar Schermelleh; Benjamin A Garcia; Emily Bernstein
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

Review 4.  Epigenetic plasticity and the hallmarks of cancer.

Authors:  William A Flavahan; Elizabeth Gaskell; Bradley E Bernstein
Journal:  Science       Date:  2017-07-21       Impact factor: 47.728

5.  Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma.

Authors:  Balakrishna Koneru; Gonzalo Lopez; Ahsan Farooqi; Karina L Conkrite; Thinh H Nguyen; Shawn J Macha; Apexa Modi; Jo Lynne Rokita; Eduardo Urias; Ashly Hindle; Heather Davidson; Kristyn Mccoy; Jonas Nance; Vanda Yazdani; Meredith S Irwin; Shengping Yang; David A Wheeler; John M Maris; Sharon J Diskin; C Patrick Reynolds
Journal:  Cancer Res       Date:  2020-04-14       Impact factor: 12.701

6.  Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.

Authors:  Joo Young Kim; Jacqueline A Brosnan-Cashman; Soyeon An; Sung Joo Kim; Ki-Byung Song; Min-Sun Kim; Mi-Ju Kim; Dae Wook Hwang; Alan K Meeker; Eunsil Yu; Song Cheol Kim; Ralph H Hruban; Christopher M Heaphy; Seung-Mo Hong
Journal:  Clin Cancer Res       Date:  2016-09-23       Impact factor: 12.531

7.  Alpha thalassemia/mental retardation syndrome X-linked gene product ATRX is required for proper replication restart and cellular resistance to replication stress.

Authors:  Justin Wai-Chung Leung; Gargi Ghosal; Wenqi Wang; Xi Shen; Jiadong Wang; Lei Li; Junjie Chen
Journal:  J Biol Chem       Date:  2013-01-16       Impact factor: 5.157

Review 8.  Molecular markers in pediatric neuro-oncology.

Authors:  Koichi Ichimura; Ryo Nishikawa; Masao Matsutani
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 9.  Neuroendocrine tumors of the pancreas: current concepts and controversies.

Authors:  Michelle D Reid; Serdar Balci; Burcu Saka; N Volkan Adsay
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 10.  Update on pancreatic neuroendocrine tumors.

Authors:  Logan R McKenna; Barish H Edil
Journal:  Gland Surg       Date:  2014-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.